Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ozvan Bocher

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Human Genetics|June 6, 2020
Rare variant association testing in the non-coding genomeOzvan Bocher, Emmanuelle Génin
Human Molecular Genetics|January 14, 2025
Insights into the molecular underpinning of type 2 diabetes complicationsArchit Singh, Ozvan Bocher, Eleftheria Zeggini
Nature Communications|June 14, 2023
Unravelling the genetic architecture of human complex traits through whole genome sequencingOzvan Bocher, Cristen J Willer, Eleftheria Zeggini
Genetic Epidemiology|May 9, 2023
Ravages: An R package for the simulation and analysis of rare variants in multicategory phenotypesOzvan Bocher, Gaëlle Marenne, Emmanuelle Génin, et al.
European Journal of Human Genetics : EJHG|January 15, 2021
Extension of SKAT to multi-category phenotypes through a geometrical interpretationOzvan Bocher, Gaelle Marenne, Elisabeth Tournier-Lasserve, et al.
HGG Advances|July 14, 2023
Bridging the diversity gap: Analytical and study design considerations for improving the accuracy of trans-ancestry genetic predictionOzvan Bocher, Arthur Gilly, Young-Chan Park, et al.
International Journal of Molecular Sciences|April 3, 2021
<i>CFTR</i> Cooperative <i>Cis</i>-Regulatory Elements in Intestinal CellsMégane Collobert, Ozvan Bocher, Anaïs Le Nabec, et al.
Cardiovascular Diabetology|January 20, 2026
Integration of clinical and proteomic risk factors enhances prognostic modelling of incident vascular complications in type 2 diabetesYue Huang, Mauro Tutino, Archit Singh, et al.
Brain Communications|October 23, 2020
Principal component analysis, a useful tool to study cyclin-dependent kinase-inhibitor's effect on cerebral ischaemiaLucas Le Roy, Ahmed Amara, Cloé Le Roux, et al.
Genetic Epidemiology|April 14, 2022
RAVAQ: An integrative pipeline from quality control to region-based rare variant association analysisGaëlle Marenne, Thomas E Ludwig, Ozvan Bocher, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Human Genetics|June 6, 2020
Rare variant association testing in the non-coding genomeOzvan Bocher, Emmanuelle Génin
Human Molecular Genetics|January 14, 2025
Insights into the molecular underpinning of type 2 diabetes complicationsArchit Singh, Ozvan Bocher, Eleftheria Zeggini
Nature Communications|June 14, 2023
Unravelling the genetic architecture of human complex traits through whole genome sequencingOzvan Bocher, Cristen J Willer, Eleftheria Zeggini
Genetic Epidemiology|May 9, 2023
Ravages: An R package for the simulation and analysis of rare variants in multicategory phenotypesOzvan Bocher, Gaëlle Marenne, Emmanuelle Génin, et al.
European Journal of Human Genetics : EJHG|January 15, 2021
Extension of SKAT to multi-category phenotypes through a geometrical interpretationOzvan Bocher, Gaelle Marenne, Elisabeth Tournier-Lasserve, et al.
HGG Advances|July 14, 2023
Bridging the diversity gap: Analytical and study design considerations for improving the accuracy of trans-ancestry genetic predictionOzvan Bocher, Arthur Gilly, Young-Chan Park, et al.
International Journal of Molecular Sciences|April 3, 2021
<i>CFTR</i> Cooperative <i>Cis</i>-Regulatory Elements in Intestinal CellsMégane Collobert, Ozvan Bocher, Anaïs Le Nabec, et al.
Cardiovascular Diabetology|January 20, 2026
Integration of clinical and proteomic risk factors enhances prognostic modelling of incident vascular complications in type 2 diabetesYue Huang, Mauro Tutino, Archit Singh, et al.
Brain Communications|October 23, 2020
Principal component analysis, a useful tool to study cyclin-dependent kinase-inhibitor's effect on cerebral ischaemiaLucas Le Roy, Ahmed Amara, Cloé Le Roux, et al.
Genetic Epidemiology|April 14, 2022
RAVAQ: An integrative pipeline from quality control to region-based rare variant association analysisGaëlle Marenne, Thomas E Ludwig, Ozvan Bocher, et al.
Pageof 3